ClinicalThought

Share

Program Content

Activities

  • CDK4/6i and PI3Ki in HR+/HER2-
    CDK4/6 and PI3K Inhibitors for HR+/HER2- Breast Cancer in the Clinic Today: Thoughts From the Experts
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 23, 2021

    Expires: March 22, 2022

  • Abemaciclib in EBC
    What to Know About the New Approval for Abemaciclib in Patients With Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 29, 2021

    Expires: November 28, 2022

Supporters

Lilly

Partners

Smart Patients

ProCE Banner